BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8679569)

  • 1. Substitution of cadmium for zinc in farnesyl:protein transferase alters its substrate specificity.
    Zhang FL; Fu HW; Casey PJ; Bishop WR
    Biochemistry; 1996 Jun; 35(25):8166-71. PubMed ID: 8679569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Farnesyl protein transferase inhibitors as potential cancer chemopreventives.
    Kelloff GJ; Lubet RA; Fay JR; Steele VE; Boone CW; Crowell JA; Sigman CC
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):267-82. PubMed ID: 9107432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fluorescence assay for geranylgeranyl transferase type I.
    Pickett WC; Zhang FL; Silverstrim C; Schow SR; Wick MM; Kerwar SS
    Anal Biochem; 1995 Feb; 225(1):60-3. PubMed ID: 7778787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel tricyclic inhibitors of farnesyl protein transferase. Biochemical characterization and inhibition of Ras modification in transfected Cos cells.
    Bishop WR; Bond R; Petrin J; Wang L; Patton R; Doll R; Njoroge G; Catino J; Schwartz J; Windsor W
    J Biol Chem; 1995 Dec; 270(51):30611-8. PubMed ID: 8530497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice.
    Liu M; Bryant MS; Chen J; Lee S; Yaremko B; Li Z; Dell J; Lipari P; Malkowski M; Prioli N; Rossman RR; Korfmacher WA; Nomeir AA; Lin CC; Mallams AK; Doll RJ; Catino JJ; Girijavallabhan VM; Kirschmeier P; Bishop WR
    Cancer Chemother Pharmacol; 1999; 43(1):50-8. PubMed ID: 9923541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Farnesyl protein transferase: identification of K164 alpha and Y300 beta as catalytic residues by mutagenesis and kinetic studies.
    Wu Z; Demma M; Strickland CL; Radisky ES; Poulter CD; Le HV; Windsor WT
    Biochemistry; 1999 Aug; 38(35):11239-49. PubMed ID: 10471273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional consequence of mutating conserved residues of the yeast farnesyl-protein transferase beta-subunit Ram1(Dpr1).
    Kurth DD; Farh L; Deschenes RJ
    Biochemistry; 1997 Dec; 36(50):15932-9. PubMed ID: 9398327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Ha-ras, N-ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type I.
    Zhang FL; Kirschmeier P; Carr D; James L; Bond RW; Wang L; Patton R; Windsor WT; Syto R; Zhang R; Bishop WR
    J Biol Chem; 1997 Apr; 272(15):10232-9. PubMed ID: 9092572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Farnesylation of p21 Ras proteins in Xenopus oocytes.
    Zhao J; Kung HF; Manne V
    Cell Mol Biol Res; 1994; 40(4):313-21. PubMed ID: 7866432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship of 3-substituted N-(pyridinylacetyl)-4- (8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene )- piperidine inhibitors of farnesyl-protein transferase: design and synthesis of in vivo active antitumor compounds.
    Njoroge FG; Vibulbhan B; Rane DF; Bishop WR; Petrin J; Patton R; Bryant MS; Chen KJ; Nomeir AA; Lin CC; Liu M; King I; Chen J; Lee S; Yaremko B; Dell J; Lipari P; Malkowski M; Li Z; Catino J; Doll RJ; Girijavallabhan V; Ganguly AK
    J Med Chem; 1997 Dec; 40(26):4290-301. PubMed ID: 9435898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
    Lobell RB; Omer CA; Abrams MT; Bhimnathwala HG; Brucker MJ; Buser CA; Davide JP; deSolms SJ; Dinsmore CJ; Ellis-Hutchings MS; Kral AM; Liu D; Lumma WC; Machotka SV; Rands E; Williams TM; Graham SL; Hartman GD; Oliff AI; Heimbrook DC; Kohl NE
    Cancer Res; 2001 Dec; 61(24):8758-68. PubMed ID: 11751396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesyl-protein transferase and geranylgeranyl-protein transferase assays using phosphocellulose paper absorption.
    Roskoski R; Ritchie P; Gahn LG
    Anal Biochem; 1994 Oct; 222(1):275-80. PubMed ID: 7856861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of farnesyl protein transferase complexed with a CaaX peptide and farnesyl diphosphate analogue.
    Strickland CL; Windsor WT; Syto R; Wang L; Bond R; Wu Z; Schwartz J; Le HV; Beese LS; Weber PC
    Biochemistry; 1998 Nov; 37(47):16601-11. PubMed ID: 9843427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging farnesyl protein transferase using a topologically activated probe.
    Pham W; Pantazopoulos P; Moore A
    J Am Chem Soc; 2006 Sep; 128(36):11736-7. PubMed ID: 16953595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeast protein geranylgeranyltransferase type-I: overproduction, purification, and characterization.
    Stirtan WG; Poulter CD
    Arch Biochem Biophys; 1995 Aug; 321(1):182-90. PubMed ID: 7639519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesylation and proteolysis are sequential, but distinct steps in the CaaX box modification pathway.
    Farh L; Mitchell DA; Deschenes RJ
    Arch Biochem Biophys; 1995 Apr; 318(1):113-21. PubMed ID: 7726551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of protein geranylgeranyltransferase I from the enteric protist Entamoeba histolytica.
    Makioka A; Kumagai M; Takeuchi T; Nozaki T
    Mol Biochem Parasitol; 2006 Feb; 145(2):216-25. PubMed ID: 16300841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oreganic acid, a potent inhibitor of ras farnesyl-protein transferase.
    Silverman KC; Jayasuriya H; Cascales C; Vilella D; Bills GF; Jenkins RG; Singh SB; Lingham RB
    Biochem Biophys Res Commun; 1997 Mar; 232(2):478-81. PubMed ID: 9125205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective modification of CaaX peptides with ortho-substituted anilinogeranyl lipids by protein farnesyl transferase: competitive substrates and potent inhibitors from a library of farnesyl diphosphate analogues.
    Troutman JM; Subramanian T; Andres DA; Spielmann HP
    Biochemistry; 2007 Oct; 46(40):11310-21. PubMed ID: 17854205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR studies of novel inhibitors bound to farnesyl-protein transferase.
    Koblan KS; Culberson JC; Desolms SJ; Giuliani EA; Mosser SD; Omer CA; Pitzenberger SM; Bogusky MJ
    Protein Sci; 1995 Apr; 4(4):681-8. PubMed ID: 7613466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.